These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 7436100)

  • 41. Field observations on the duration of immunity in cattle after vaccination against Anaplasma and Babesia species.
    Tjornehoj K; Lawrence JA; Whiteland AP; Kafuwa PT
    Onderstepoort J Vet Res; 1996 Mar; 63(1):1-5. PubMed ID: 8848296
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical chemistry of anaplasmosis: comparative serum protein changes elicited by attenuated and virulent Anaplasma marginale isolates.
    Allen PC; Kuttler KL; Amerault TE
    Am J Vet Res; 1981 Feb; 42(2):326-8. PubMed ID: 7258784
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of sequential coinfection with Anaplasma phagocytophilum and Anaplasma marginale in cattle.
    Hoar BR; Nieto NC; Rhodes DM; Foley JE
    Am J Vet Res; 2008 Sep; 69(9):1171-8. PubMed ID: 18764690
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anaplasma ovis in Idaho sheep.
    Magonigle RA; Eckblad WP; Lincoln SD; Frank FW
    Am J Vet Res; 1981 Feb; 42(2):199-201. PubMed ID: 7258767
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anaplasma marginale Yucatan (Mexico) Strain. Assessment of low virulence and potential use as a live vaccine.
    Rodríguez Camarillo SD; García Ortiz MA; Rojas Ramírez EE; Cantó Alarcón GJ; Preciado de la Torre JF; Rosario Cruz R; Ramos Aragón JA; Aboytes Torres R
    Ann N Y Acad Sci; 2008 Dec; 1149():98-102. PubMed ID: 19120183
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immune responses of cows to a chemically modified anaplasma antigen.
    Buening GM
    Am J Vet Res; 1978 Jun; 39(6):925-30. PubMed ID: 666088
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Methods to improve the health of cattle in the tropics: immunisation and chemoprophylaxis against haemoparasitic infections.
    Thompson KC; Todorovic RA; Mateus G; Adams LG
    Trop Anim Health Prod; 1978 May; 10(2):75-81. PubMed ID: 664017
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Response of cattle upon reexposure to Anaplasma marginale after elimination of chronic carrier infections.
    Magonigle RA; Newby TJ
    Am J Vet Res; 1984 Apr; 45(4):695-7. PubMed ID: 6731981
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunization with an isolate-common surface protein protects cattle against anaplasmosis.
    Palmer GH; Barbet AF; Davis WC; McGuire TC
    Science; 1986 Mar; 231(4743):1299-302. PubMed ID: 3945825
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular and serological detection of A. centrale- and A. marginale-infected cattle grazing within an endemic area.
    Molad T; Mazuz ML; Fleiderovitz L; Fish L; Savitsky I; Krigel Y; Leibovitz B; Molloy J; Jongejan F; Shkap V
    Vet Microbiol; 2006 Mar; 113(1-2):55-62. PubMed ID: 16300909
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development of a Babesia bovis live attenuated vaccine.
    Alonso M; Blandino T; Mendoza E; Savon L; Camacho M
    Arch Med Res; 1994; 25(2):273-7. PubMed ID: 7919825
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Estimation of the potential demand for a bovine babesiosis and anaplasmosis vaccine in Argentina.
    Späth EJ; Mangold AJ; Guglielmone AA
    Vet Parasitol; 1990 May; 36(1-2):131-40. PubMed ID: 2382381
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Response of calves to lung challenge exposure with Pasteurella haemolytica after parenteral or pulmonary immunization.
    Wilkie BN; Markham RJ; Shewen PE
    Am J Vet Res; 1980 Nov; 41(11):1773-8. PubMed ID: 7212406
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of immune responses of cattle to erythrocyte stroma, Anaplasma antigen, and dodecanoic acid-conjugated Anaplasma antigen: cell-mediated immunity.
    Francis DH; Buening GM; Amerault TE
    Am J Vet Res; 1980 Mar; 41(3):368-71. PubMed ID: 7369609
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparative response to premunization using attenuated Anaplasma marginale virulent A. marginale and A. centrale in different age groups.
    Kuttler KL
    Trop Anim Health Prod; 1972; 4(4):197-203. PubMed ID: 4671458
    [No Abstract]   [Full Text] [Related]  

  • 56. Genetic diversity of Anaplasma marginale strains from an outbreak of bovine anaplasmosis in an endemic area.
    Almazán C; Medrano C; Ortiz M; de la Fuente J
    Vet Parasitol; 2008 Nov; 158(1-2):103-9. PubMed ID: 18842342
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genetically modified live vaccine offers protective immunity against wild-type Anaplasma marginale tick-transmission challenge.
    Ferm J; Jaworski DC; Stoll I; Kleinhenz MD; Kocan KM; Madesh S; Ferm D; Liu H; Fitzwater S; Schlieper A; Ganta RR
    Vaccine; 2024 Oct; 42(24):126069. PubMed ID: 38880695
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mortality, weight loss and anaemia in Bos taurus calves exposed to Boophilus microplus ticks in the tropics of Colombia.
    Corrier DE; Vizcaino O; Terry M; Betancourt A; Kuttler KL; Carson CA; Trevino G; Ristic M
    Trop Anim Health Prod; 1979 Nov; 11(4):215-21. PubMed ID: 552671
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Frozen Anaplasma centrale vaccine against anaplasmosis in cattle.
    Pipano E; Krigel Y; Frank M; Markovics A; Mayer E
    Br Vet J; 1986; 142(6):553-6. PubMed ID: 3594187
    [No Abstract]   [Full Text] [Related]  

  • 60. Productivity and health effects of anaplasmosis and babesiosis on Bos indicus cattle and their crosses, and the effects of differing intensity of tick control in Australia.
    Jonsson NN; Bock RE; Jorgensen WK
    Vet Parasitol; 2008 Aug; 155(1-2):1-9. PubMed ID: 18472219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.